Interpace Biosciences, Inc. Stock
Stocks
IDXG
US46062X3035
Healthcare Facilities & Services
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.630 USD | +1.24% |
|
-0.61% | +32.50% |
| Market Cap | 45.15M 39.45M 36.23M 33.79M 64.05M 4.3B 65.13M 436M 169M 2.11B 170M 166M 7.26B | P/E 2024 |
6.84x | P/E 2025 | 1.39x |
|---|---|---|---|---|---|
| Enterprise Value | 43.83M 38.3M 35.17M 32.8M 62.18M 4.17B 63.23M 423M 164M 2.05B 165M 161M 7.05B | EV / Sales 2024 |
0.35x | EV / Sales 2025 | 0.11x |
| Free-Float |
14.74% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +1.24% | ||
| 1 week | -0.61% | ||
| 1 month | -7.39% | ||
| 3 months | -16.73% | ||
| 6 months | +36.97% | ||
| Current year | +32.50% |
| 1 week | 1.6 |  | 1.8 |
| 1 month | 1.57 | | 1.8 |
| Current year | 1.03 | | 2.4 |
| 1 year | 0.76 | | 2.4 |
| 3 years | 0.44 | | 3.54 |
| 5 years | 0.44 | | 10.5 |
| 10 years | 0.44 | | 198 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Burnell
CEO | Chief Executive Officer | 63 | 2020-11-30 |
| Director of Finance/CFO | 34 | 2023-04-20 | |
Nicole Massoll
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Sullivan
CHM | Chairman | 78 | 2016-06-20 |
Joseph Keegan
BRD | Director/Board Member | 73 | 2015-12-31 |
Fortunato Rocca
BRD | Director/Board Member | 64 | 2020-01-21 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 01-19 | 1315 Capital LLC
| Conversion | Company | 9,405,941 | 212.3938% | |
| 01-19 | Ampersand Management LLC
| Conversion | Company | 13,861,386 | 313.0013% | |
| 24-01-31 | Free | Chief Financial Officer | 10,000 | 0.2314% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.24% | -0.61% | +112.96% | +48.18% | 44.6M | |
| +1.10% | +7.13% | +72.88% | +474.02% | 39.57B | |
| +1.09% | +7.75% | +10.38% | +18.92% | 23.28B | |
| +1.03% | +3.50% | -21.28% | -40.90% | 7.15B | |
| +4.77% | +14.56% | +23.54% | +110.76% | 5.16B | |
| +1.68% | -2.30% | +19.03% | +46.08% | 2.85B | |
| -5.86% | -1.69% | -24.81% | +1,032.72% | 2.13B | |
| +1.27% | +10.42% | +104.86% | -5.66% | 1.95B | |
| -0.93% | +2.42% | +37.60% | -20.76% | 1.84B | |
| +2.47% | +2.14% | +20.92% | -1.68% | 1.61B | |
| Average | +0.79% | +4.42% | +35.61% | +166.17% | 8.56B | |
| Weighted average by Cap. | +1.14% | +6.97% | +39.82% | +254.17% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 46.93M 41M 37.65M 35.11M 66.57M 4.47B 67.69M 453M 176M 2.19B 176M 172M 7.55B | 38.73M 33.84M 31.07M 28.98M 54.94M 3.69B 55.87M 374M 145M 1.81B 145M 142M 6.23B |
| Net income | 6.7M 5.86M 5.38M 5.01M 9.51M 638M 9.67M 64.75M 25.09M 313M 25.16M 24.62M 1.08B | 24.58M 21.47M 19.72M 18.39M 34.86M 2.34B 35.45M 237M 92.01M 1.15B 92.27M 90.27M 3.95B |
| Net Debt | 4.4M 3.84M 3.53M 3.29M 6.23M 418M 6.34M 42.46M 16.46M 205M 16.5M 16.14M 707M | -1.32M -1.16M -1.06M -989K -1.88M -126M -1.91M -12.77M -4.95M -61.73M -4.96M -4.86M -213M |
Employees
102
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-02 | US$1.630 | +1.24% | 1,100 |
| 26-07-01 | US$1.610 | -1.23% | 2,190 |
| 26-06-30 | US$1.630 | -2.98% | 16,175 |
| 26-06-29 | US$1.680 | +1.82% | 2,403 |
| 26-06-26 | US$1.650 | +0.61% | 2,333 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- IDXG Stock
Select your edition
All financial news and data tailored to specific country editions
